Bone Marrow vs Liver as Site for Islet Transplantation (IsletBOM2)
Bone Marrow vs Liver as Site for Islet Transplantation in Patients With Type 1 Diabetes: Pilot Study to Evaluate Efficacy
Sponsor: Ministry of Health, Italy
A PHASE1/PHASE2 clinical study on Type 1 Diabetes, this trial is completed. The trial is conducted by Ministry of Health, Italy and has accumulated 7 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
-
Dec 2020 — Jan 2021 [monthly]
Completed PHASE1_PHASE2
-
Jun 2018 — Dec 2020 [monthly]
Completed PHASE1_PHASE2
▶ Show 2 earlier versions
-
Mar 2018 — Jun 2018 [monthly]
Completed PHASE1_PHASE2
Status: Active Not Recruiting → Completed
-
Jan 2017 — Mar 2018 [monthly]
Active Not Recruiting PHASE1_PHASE2
First recorded
Jun 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ministry of Health, Italy
- Ospedale San Raffaele
For direct contact, visit the study record on ClinicalTrials.gov .